Bryant R. England

Has grant

Associate Professor of Medicine

University of Nebraska Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Bryant R. England is an Associate Professor of Medicine at the University of Nebraska Medical Center, located in the United States. His research focuses on rheumatology, particularly the genetic and clinical factors influencing pain management and disease outcomes in rheumatoid arthritis and gout. Recent studies include the development of genetic risk scores and an analysis of health-related quality of life improvements in patients receiving targeted therapies.

Recent Grants

Grant: Close

Epidemiology of Multimorbidity in Rheumatoid Arthritis

Open Date: 2018-07-01

Close Date: 2021-06-30

Grant: Close

Enhancing the Identification of Rheumatoid Arthritis Associated Lung Disease

Open Date: 2017-07-01

Close Date: 2018-06-01

Grant: Close

Determinants of Cardiovascular Disease Mortality in a High-Risk Rheumatoid Arthritis Cohort

Open Date: 2014-09-01

Close Date: 2014-11-01

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

View details

Beth Wallace

Assistant Professor

University of Michigan Hospital

UNITED STATES

View details

Grant Cannon

University of Utah

UNITED STATES

View details

Ted R Mikuls

University of Nebraska Medical Center

UNITED STATES

View details

Joshua F. Baker

University of Pennsylvania School of Medicine

UNITED STATES

View details

Kaleb Michaud

Professor

University of Nebraska Medical Center

UNITED STATES

View details

Brian Sauer

Associate Professor

University of Utah

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bryant R. England

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (29)

Heterogeneity of Rheumatoid Arthritis‐Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations with Disease Outcomes

Genetically-determined variation in CRP impacts disease activity assessment in rheumatoid arthritis

Development and External Validation of a Genetic Risk Score for Pain in Rheumatoid Arthritis

Adipokines and Associations with Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis

Agreement of Administrative Pharmacy Dispensing With Self‐Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis

Improvements in Health‐Related Quality of Life with Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post‐hoc Analysis of a Randomized Multicenter Trial

Chronic Opioids in Gout: A Matched Cohort Study from the Veteran's Health Administration

Reply

EULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of Arthralgia

Reply

Classifying Multimorbidity Using Drug Concepts via the <scp>Rx‐Risk</scp> Comorbidity Index: Methods and Comparative <scp>Cross‐Sectional</scp> Study

Changes in Characteristics of Patients Initiating and Discontinuing Advanced Therapies for Rheumatoid Arthritis Following the Release of Safety Data

Reply

Comparison of Gout Flares With the Initiation of Treat‐to‐Target Allopurinol and Febuxostat: A Post‐Hoc Analysis of a Randomized Multicenter Trial

Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritis

Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted‐Synthetic Disease‐Modifying Antirheumatic Drugs

Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout

Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis

Using Electronic Health Records and Linked Claims Data to Assess New Medication Use and Primary Nonadherence in Rheumatology Patients

Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health System

Lowering Expectations: Glucocorticoid Tapering Among Veterans With Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic Therapy

A Narrowing Mortality Gap: Temporal Trends of Cause‐Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis

Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD‐10‐CM Diagnostic Codes

Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis

2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis

2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis

Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics

Response to: ‘Correspondence on ‘Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis’’ by Ruscittiet al

Cause‐Specific Mortality in Patients With Gout in the US Veterans Health Administration: A Matched Cohort Study

Collaborators (11)

Tate Johnson

Jennifer Barton

Louise Thoma

Katherine Wysham

Huifeng Yun

Beth Wallace

Grant Cannon

Ted R Mikuls

Joshua F. Baker

Kaleb Michaud

Brian Sauer

Make your next move.